Transitional cell carcinoma of the corpus uteri Advocacy Hub | UniteRare

At a Glance

Live from database

Regulatory Watchboard

1 event

Aug 2017Sapanisertib in Treating Patients With Locally Advanced or Metastatic Bladder Cancer With TSC1 and/or TSC2 Mutations

National Cancer Institute (NCI) — PHASE2

TrialACTIVE NOT RECRUITING

Data from FDA regulatory filings and ClinicalTrials.gov. Updated periodically.

Financial Assistance

FINANCIAL LANDSCAPE SUMMARY

Total programs

No financial assistance programs currently listed for Transitional cell carcinoma of the corpus uteri.
Check the disease page for updates →

Clinical Trial Landscape

No active clinical trials currently recruiting for Transitional cell carcinoma of the corpus uteri.
Search all trials →

Search clinical trials for Transitional cell carcinoma of the corpus uteri →

Recent News & Research

No recent news articles indexed yet for Transitional cell carcinoma of the corpus uteri.
Search PubMed for Transitional cell carcinoma of the corpus uteri →

Browse all Transitional cell carcinoma of the corpus uteri news →

Specialist Network

Top 5 by expertise

Don Dizon, MD

NRG Oncology

📍 PROVIDENCE, RI

Score 114 trials

Matthew Powell

NRG Oncology

Score 41 trial14 pubs

Vicky Makker, MD

NRG Oncology

📍 NEW YORK, NY

Score 41 trial

Yanyan Lou, MD, PhD, MD

Mayo Clinic

📍 JACKSONVILLE, FL

Score 41 trial

Joseph W Kim

Los Angeles General Medical Center

📍 Los Angeles, California

Score 01304 pubs

View all Transitional cell carcinoma of the corpus uteri specialists →

Quick Actions

📄

View Disease Page

Full profile, treatments, community

🔬

Search Clinical Trials

Find recruiting studies now

🩺

Find Specialists

Ranked by expertise & trials

💰

Financial Assistance

Copay cards, PAPs, grants

📰